Pharmaceuticals & Healthcare Industry Research

Pharmaceuticals & Healthcare Industry Research

About

Bio

Background and Format: They monitor 115 countries and aim to keep readers up-to-date with key developments including market forecast trends, monthly and annual trade performance, healthcare reforms, government investment programmes, regulatory developments, production changes, leading national and multinational manufacturers and competitive strategies. Audience and Readership: Decision makers from multinational corporations, banks and insurance companies, medical companies, consultancies and sector specialists and government departments Frequency: It is on a 13-month rolling basis Circulation: No figure available Other Information: It is best to direct enquiries to enquiry@bmiresearch.com or contact via the form here Alerts: Gorkana alert: Thursday 27th September 2007 Espicom Business Intelligence the healthcare publishers, have restructured their communications network. Principal staff contacts are as follows: Andrew Crofts, Primary Editor covering healthcare markets (world pharmaceutical markets and medistat) - +44 (0)1243 756 003 and andrew_crofts@espicom.com Jeremy Webber, Primary Editor covering pharmaceutical companies analysis - +44 (0)1243 756 024 and jeremy_webber@espicom.com Fiona Cowie, Primary Editor covering pharmaceutical news - +44 (0)1243 756 013 and fiona_cowie@espicom.com Lawrence Miller, Primary Editor covering medical device news - +44 (0)1243 756 031 and lawrence_miller@espicom.com Chris Swann, Press contact / Market briefings - +44 (0)1243 756 054 and chris_swann@espicom.com Julie Ash, Business development - +44 (0)1243 756 027 and julie_ash@espicom.com Publications include: Anti-Infective Drug News, Autoimmune Drug Focus, Cancer Drug News, Cardiovascular Device Business, Cardiovascular Drug News, CNS Drug News, Drug Delivery Insight, Medical Imaging Business, Medical Industry Week, Neuro Drug Focus, Orthopaedics Business, Pharma Agreement News, Pharma Company Insight, The Diabetes Report, World Generic Markets, Generic Companies Analysis, Generic Markets Analysis, Medical Device Companies Analysis, Medistat - World Medical Markets Analysis and World Pharmaceutical Markets. All press releases should be sent to healthcare@espicom.com and general enquiries via +44 (0)1243 533 322

Email

email@cision.one

Website

site@cision.one

Social media

linkedin x facebook reddit

Location

United Kingdom

Frequency

upgrade

Circulation

upgrade

Sectors

Pharmaceuticals


Is this you? We'd love to hear from you, contact our journalist team.
Contact us to unlock the full profile

Most recent articles by Pharmaceuticals & Healthcare Industry Research

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet
Contact us to explore recent articles

Explore outlets similar to Pharmaceuticals & Healthcare Industry Research

  • Science
    Science

    Founded in 1880, with seed money from Thomas Edison, Science continues to be at the center of the very best in research across the sciences, with articles that consistently rank among the most cited in the world. Science articles are peer-reviewed, and written to appeal to both scientist and layman. Regular issue features include a news and comment section, book reviews, and coverage of scientific meetings and seminars. The News section features late-breaking news and in-depth news analysis. Compass, an opinion section, publishes letters and commentary by scientists on current science issues. The TechSight section focuses on leading edge techniques and technologies. Topics include: bioinformatics, genome sequencing, and protein sequencing. This section is published in the third issue every month. The Research section features original investigative research and reporting. Other departments include NetWatch, This Week in Science, ScienceScope, Random Samples and New Products.

    View
  • Medscape
    Medscape

    Medscape was created for medical specialists, primary care physicians, and health professionals and offers medical news, clinical trial information, review articles, journal commentary, expert columns, patient education articles and book reviews. It also includes Web-based services for verifying insurance information, Medline and other search engines, as well as a physician directory enabling users to find physicians by practice, location or specialty.

    View
  • Endpoints News
    Endpoints News

    Endpoints News covers Biopharmaceutical industry. Offers data-driven news and analysis for industry professionals covering research and development. Content is a combination of originally produced and curated from around the web and is available in real-time and via a daily newsletter. This site is available via RSS (Really Simple Syndication).

    View
  • The Pharmaceutical Journal
    The Pharmaceutical Journal

    Background and Format: The Pharmaceutical Journal is published by the Royal Pharmaceutical Society monthly and aimed at community pharmacists, pharmaceutical scientists, independent prescribers, hospital pharmacists, pharmacy students, technicians, industrial pharmacists, pre-registration trainees, regulatory pharmacists, academics, pharmacy owners, healthcare policy makers and other healthcare professionals. Covers news & analysis, learning, research, comment, books & art and careers. It also has sister publications Clinical Pharmacist and Tomorrow's Pharmacist. The media pack is available from: http://www.pharmaceutical-journal.com/services/advertise/#reach Circulation: Source: Publisher   Alerts: Gorkana UK Financial Alert: Monday 2nd November 2015 The Pharmaceutical Journal, the official journal of the Royal Pharmaceutical Society, which caters for pharmacists and pharmaceutical scientists, is relaunching from a 32-page publication 40 times per year, into a new 64-page publication 12 times per year. The journal will continue to cover news, analysis, features, opinion, learning and careers articles, providing insight and knowledge about drugs, pharmacy practice, medicines use and healthcare policy in the context of the pharmacy profession and pharmaceutical sciences. The Pharmaceutical Journal’s sister publication Clinical Pharmacist has increased frequency from 10 to 12 issues. Starting January 2016 it will publish peer-reviewed review, perspective and evidence-based CPD articles on topics from drug discovery to clinical pharmacology and pharmacy. It will also carry practice reports on best practice in pharmacy and pharmaceutical sciences. The site, which will remain updated daily, can be viewed at www.pharmaceutical-journal.com. News and Views Editor Harriet Adcock can be reached at harriet.adcock@pharmaceutical-journal.com and Deputy News Editor Elizabeth Sukkar can be reached at elizabeth.sukkar@pharmaceutical-journal.com Gorkana Alert: Monday 21 July 2014 The Pharmaceutical Journal, the official journal of the Royal Pharmaceutical Society, which caters for Pharmacists and Pharmaceutical Scientists, launched a new website and print magazine this month. The journal covers news, features and articles on pharmacy, healthcare policy and clinical science. The editorial team welcomes freelance contributors for news and features. The site can be viewed at www.pharmaceutical-journal.com. News Editor Harriet Adcock can be reached at harriet.adcock@pharmaceutical-journal.com and Deputy News Editor Elizabeth Sukkar can be reached at elizabeth.sukkar@pharmaceutical-journal.com Gorkana Alert: Wednesday 22 August 2012 Ayshe Ismail, previously the Editorial Assistant at The Pharmaceutical Journal, has left. The Pharmaceutical Journal is the official journal of the Royal Pharmaceutical Society and aims to provide comprehensive news coverage on all aspects of pharmacy and to publish original research and articles on pharmaceutical and related subject

    View
  • Nature Reviews Drug Discovery
    Nature Reviews Drug Discovery

    Impact Factor:22.66 (Source: Scimago Journal & Country Rank)Circulation: The figure is not currently disclosed.Aims of the journal:Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition it seeks to provide the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.Content: The journal covers the following subjects: Target discovery Rational drug design Combinatorial and parallel synthesis Medicinal chemistry Key compound classes Natural products High-throughput screening Novel therapeutic approaches to disease states Microarrays Bioinformatics and chemoinformatics Absorption, distribution, metabolism and elimination (ADME) Pharmacokinetics and pharmacodynamics Pharmacology Toxicology Pharmacogenomics and toxicogenomics Drug delivery Biopharmaceuticals Biotechnology Vaccines Clinical trial evaluation Regulatory issues PharmacoeconomicsEditorial contacts: See the list of editors here.The editorial office can be reached at naturereviews@nature.com.Manuscript submission:To be published in nature Reviews Drug Discovery a manuscript should meet the following criteria: Timely, accurate and balanced Important to scientists in the specific field Interesting and accessible to researchers in other areas of Drug DiscoverySubmit online at http://mts-nrdd.nature.com/cgi-bin/main.plex

    View
Use CisionOne to find more relevant outlets

Contact Pharmaceuticals & Healthcare Industry Research and get access to over 850K accurate, up-to-date media profiles.

Discover the stories that impact your brand. In realtime.

CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.